Choose HA†
Prescribing Information   |  OAKneePainRelief.com
Logo GELSYN-3
Logo GELSYN-3
  • About OA*
    • What is OA*
    • Symptoms
    • Causes
    • Diagnosis
    • Treatment Options
    • OA Self-Assessment Tool
    • My OA Support
  • Choose GELSYN-3
    • Choose GELSYN-3
    • What is GELSYN-3?
    • How GELSYN-3 works
    • Is GELSYN-3 right for me?
    • Resources
    • FAQ
    • Patient Rebate
    • How to get GELSYN-3
  • For Healthcare Providers
    • Proven HA Innovation†
    • Science-driven Results
    • Safety
    • Resources
    • Journal Articles
    • Videos
    • Contact a Rep
  • Contact Us
  • KneeMail
  • Get GELSYN-3
2.5-header-iStock-625281998

Learn More About Osteoarthritis

Many great resources about new arthritis therapies, arthritis education and community events are available.
Here are a few to start with:

AF-Logo-color500-Sphere

Arthritis Foundation

Click here to learn more
OAAA_Logo_WebBlue1

Osteoarthritis Action Alliance

 

Click here to learn more
arthritis-national-research-foundation-weblogo-1

Arthritis National Research Foundation

 

Click here to learn more
logo-color-2

The Arthritis Research Institute of America

 

Click here to learn more
apta

Physical Therapist’s Guide to Osteoarthritis.

American Physical Therapy Association

Click here to learn more

DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g., acetaminophen. Risks include general knee pain and pain at the injection site.

View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM

Summary of Indications for Use:
DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

DUROLANE has not been tested in pregnant or lactating women, or children.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Logo Bioventus
Contact us
Find a Physician
KneeMail
Facebook
  • What is OA*
  • Causes
  • Symptoms
  • Diagnosis
  • Treatment Options
  • My OA Support
  • GELSYN-3
  • What is GELSYN-3?
  • How GELSYN-3 works
  • Is GELSYN-3 right for me?
  • Resources
  • FAQ
  • Patient Rebate
  • For Healthcare Providers
  • Proven HA Innovation
  • Science driven results
  • Safety data
  • Resources
  • Journal articles
  • Videos

© Copyright 2022 Bioventus LLC | References | Prescribing Information | Privacy Policy | Copyright & Disclaimer | All Rights Reserved
GELSYN-3, Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

*Osteoarthritis     †Hyaluronic Acid

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies
Cookie name Description Cookie Type Expiration
_ga Registers a unique ID that is used to generate statistical data on how the visitor uses the website. Statistic 2 years
_gat Used by Google Analytics to throttle request rate Statistic 1 day
_gid Registers a unique ID that is used to generate statistical data on how the visitor uses the website. Statistic 1 day
Facebook Used to measure the effectiveness of Facebook ads, define custom audiences for ad targeting,  dynamic ads campaigns, and analyze the effectiveness of the website’s conversion funnels. Uses first-party and third-party cookies. Marketing 180 days
spu_closing Stores information if a popup window was closed. Marketing 30 days

Please enable Strictly Necessary Cookies first so that we can save your preferences!